The Nomination Committee proposes that Fredrik Lindberg is elected to the Board of Directors
Enzymatica’s Nomination Committee proposes to the Annual General Meeting on May 5, 2020 that Bengt Baron, Marianne Dicander Alexandersson, Guðmundur Pálmason, Mats Andersson and Louise Nicolin are re-elected, and that Fredrik Lindberg, the company’s present CEO, will replace Sigurgeir Guðlaugsson, who will not be seeking re-election.As announced earlier, Fredrik Lindberg will leave the company at summer after having accepted a job offer from a private pharmaceutical company that does not compete with Enzymatica. · “We are very pleased that Fredrik is at disposal to be elected to the